Edwards Lifesciences Corporation
Prognozy (mln)
Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
Przychód (średnia) |
5,795.23 |
5,979.91 |
6,562.73 |
7,242.29 |
8,030.39 |
8,743.80 |
Przychód Δ r/r |
0.00% |
3.19% |
9.75% |
10.35% |
10.88% |
8.88% |
Przychód (min) |
5,332.79 |
5,959.33 |
6,301.21 |
7,225.85 |
7,835.43 |
8,531.53 |
Przychód (max) |
5,864.10 |
6,031.38 |
6,764.53 |
7,258.73 |
8,172.15 |
8,898.16 |
EBITDA (średnia) |
1,825.31 |
1,883.48 |
2,067.05 |
2,281.09 |
2,529.31 |
2,754.02 |
EBIT (średnia) |
1,656.40 |
1,709.19 |
1,875.77 |
2,070.00 |
2,295.26 |
2,499.17 |
EBIT % |
28.58% |
28.58% |
28.58% |
28.58% |
28.58% |
28.58% |
Zysk netto (średni) |
1,502.99 |
1,494.36 |
1,680.23 |
1,734.25 |
2,163.92 |
2,396.00 |
Zysk netto % |
25.93% |
24.99% |
25.60% |
23.95% |
26.95% |
27.40% |
EPS (średnia) |
2.57 |
2.49 |
2.79 |
3.14 |
3.61 |
4.00 |
Liczba analityków (Przychody) |
18 |
21 |
31 |
24 |
11 |
23 |
Liczba analityków (EPS) |
11 |
22 |
22 |
10 |
5 |
4 |
symbol |
EW |
EW |
EW |
EW |
EW |
EW |